Register now for Fin24 Dashboard and get access to portfolios, watchlists, financial comparison tools, and a whole lot more to help you achieve your financial goals.

Data provided by McGregor BFA
All data is delayed
Loading...
Where am I? Home
 
Prices are delayed by 15min.
Join the Fin24.com conversation about JSE-listed stock by using every time you tweet.

Adcock eyes new opportunities

Oct 07 2009 07:33

Related Articles

Tiger places 10m shares in Adcock

Making the fat cats pay

Shares that pay in time

Small caps back in vogue?

Adcock to save R128m on tax

SA sued for AIDS drug tender

 

Top Stories

Gauteng road project costs rocket

May 25 2012 13:58

The costs of the first phase of the Gauteng Freeway Improvement Project have increased significantly to almost R90bn, according to a report.

Sizeable drop in petrol price expected

May 24 2012 17:31

The Reserve Bank will maintain current interest rates, and a considerable reduction in the local petrol price is anticipated, says governor Gill Marcus.

JSE halts 'incorrect' trade

May 25 2012 11:36

The JSE has identified and stopped "incorrect" trades from one of its members, and will reverse the trades and lower the session's total value after the close.

 
Share Share line Print

Johannesburg - South African drug maker Adcock Ingram is eyeing expansion opportunities in India and East Africa and is also planning to bolster its fast-moving consumer goods (FMCG) portfolio.

Adcock, which was unbundled from Tiger Brands in 2008 and in the process lost its FMCG products, is seeking new revenue streams after failing to buy its smaller rival Cipla Medpro.

"We're aggressively looking at East Africa for expansion," Jonathan Louw, the company's chief executive officer, told reporters at a briefing on Tuesday. The company plans to sell branded over-the-counter medicines in its Africa expansion drive.

Louw said that the company was also scanning India for expansion opportunities.

"We've been looking very closely at India in the past year," Andy Hall, the group's chief financial officer, said.

During the unbundling, Adcock gave up most of its FMCG items such as Ingram's Campher Cream and it is now planning to compete with former parent Tiger Brands in some areas.

"We cannot be like Tiger Brands but we'll compete with them on certain categories of FMCG," Louw said, adding the long-term plan was to double the sales contribution of FMCG to 20%.

Stepping stone

Adcock, the biggest over-the-counter medicine maker in South Africa, bought personal care and supplements business TLC earlier this year, which Louw said would be used as a stepping stone to launch other personal care products.

In June Adcock scrapped a R2.1bn plan to buy Cipla Medpro, dashing hopes to boost its share in the fast-growing generic market and bolster its respiratory portfolio.

The deal would have allowed it to compete more effectively with larger rival Aspen, which embarked on a string of deals aimed at strengthening its international operations.

The company, which reports year-end results next month, had seen its generic drugs business hold up well thanks to strong volume growth in anti-retrovirals, Louw said.

But sales of OTC products such as Compral came under pressure as a recession in Africa's biggest economy forced consumers to scale down in pack sizes or move to lower-priced brands, he said.

"When people can't afford, we saw a huge downtrading in OTC markets, but trusted brands such as Panado are doing well," Louw said.

Adcock, which has announced plans to sell a stake to black investors as part of a government affirmative action drive, would make an announcement by the end of the calendar year, Louw said.

The deal would include its own black staff as well as strategic shareholders, including black investment groups.

- Reuters

 
 
Comment on this story
0 comments
Comments have been closed for this article.
Facebook's intrinsic value
May 23 2012 11:32

When it comes to judging a company’s worth, value investors like Warren Buffett look at intrinsic value. By that measure, Facebook’s shares are worth less than $10. A Reuters analyst breaks down the math. (Reuters)

NicolaaSmith

CIPPA equals automatic zero erosion in the constant item economy We do not have stable – as in fixed real value – money. The real value of money is generally accepted by the public at large to be stable – as in fixed – in low inflation economies, but this is not true. The be... Read their blog...

Recently updated
Podcasts
The Sishen saga

Legal expert Peter Leon on the increasingly complex legal wrangle over the Sishen Iron Ore mine. Time: 8:17 Listen Here...

Before you list

Is the clarion call of the JSE calling? Listen to Fin24’s expert panel discussion before you list your small business. Time: 17:29

Compare and Buy

Compare and apply for hundreds of financial products from many suppliers.

Credit cards Medical aid Current accounts Think Money

Money Clinic

Money Clinic Do you have a question about your finances? We'll get an expert opinion.
Click here...

Loading...